Hui L, Chen X, Huang M, Jiang Y, Liu T
Int J Mol Sci. 2025; 26(5).
PMID: 40076567
PMC: 11900955.
DOI: 10.3390/ijms26051941.
Yuan H, Xu R, Li S, Zheng M, Tong Q, Xiang M
MedComm (2020). 2025; 6(3):e70121.
PMID: 40060195
PMC: 11890166.
DOI: 10.1002/mco2.70121.
Gnanaskandan S, Srikanth P
Cureus. 2024; 16(10):e71308.
PMID: 39529759
PMC: 11552464.
DOI: 10.7759/cureus.71308.
Ji J, Tang J, Ren P, Cai W, Shen M, Wang Q
Front Genet. 2022; 13:986322.
PMID: 36176304
PMC: 9513674.
DOI: 10.3389/fgene.2022.986322.
Zeng P, Yin W
Cell Cycle. 2022; 22(1):38-56.
PMID: 35946607
PMC: 9769453.
DOI: 10.1080/15384101.2022.2109899.
Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs.
Du F, Sun H, Sun F, Yang S, Tan H, Li X
Front Pharmacol. 2022; 13:924523.
PMID: 35747750
PMC: 9209752.
DOI: 10.3389/fphar.2022.924523.
Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection.
You H, Qin S, Zhang F, Hu W, Li X, Liu D
Front Immunol. 2022; 13:829923.
PMID: 35251017
PMC: 8891514.
DOI: 10.3389/fimmu.2022.829923.
Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System.
Lee A, Park Y, Dezhbord M, Kim K
Viruses. 2022; 14(2).
PMID: 35215970
PMC: 8874586.
DOI: 10.3390/v14020373.
Hepatitis B virus X protein promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating SOCS1.
Kang I, Kim J, Kim J, Lee J, Kim M, Ahn J
BMB Rep. 2022; 55(5):220-225.
PMID: 35168698
PMC: 9152579.
The Crosstalk Between Regulatory Non-Coding RNAs and Nuclear Factor Kappa B in Hepatocellular Carcinoma.
Zhang Y, Shao J, Li S, Liu Y, Zheng M
Front Oncol. 2021; 11:775250.
PMID: 34804980
PMC: 8602059.
DOI: 10.3389/fonc.2021.775250.
Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC).
Banerjee I, Fisher P, Sarkar D
Adv Cancer Res. 2021; 152:329-381.
PMID: 34353442
PMC: 8796124.
DOI: 10.1016/bs.acr.2021.05.003.
The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets.
Cui J, Shen H, Lim L
Pharmaceuticals (Basel). 2020; 13(12).
PMID: 33260729
PMC: 7760785.
DOI: 10.3390/ph13120432.
Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease.
de Gregorio E, Colell A, Morales A, Mari M
Int J Mol Sci. 2020; 21(11).
PMID: 32485811
PMC: 7312021.
DOI: 10.3390/ijms21113858.
Mitochondria ubiquitin ligase, MARCH5 resolves hepatitis B virus X protein aggregates in the liver pathogenesis.
Yoo Y, Park Y, Lee H, Oanh N, Cho M, Heo J
Cell Death Dis. 2019; 10(12):938.
PMID: 31819032
PMC: 6901512.
DOI: 10.1038/s41419-019-2175-z.
Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model.
Teng C, Yu C, Chang H, Hsieh W, Wu T, Lin J
Sci Rep. 2019; 9(1):10338.
PMID: 31316146
PMC: 6637187.
DOI: 10.1038/s41598-019-46891-5.
Up-regulation of brain-expressed X-linked 2 is critical for hepatitis B virus X protein-induced hepatocellular carcinoma development.
Huang F, Cai P, Wang Y, Zhou X, Chen H, Liao W
Oncotarget. 2017; 8(39):65789-65799.
PMID: 29029472
PMC: 5630372.
DOI: 10.18632/oncotarget.19477.
HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma.
Gao Q, Wang K, Chen K, Liang L, Zheng Y, Zhang Y
Cancer Sci. 2017; 108(7):1328-1337.
PMID: 28498550
PMC: 5497798.
DOI: 10.1111/cas.13277.
Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
Kong F, Hu W, Zhou K, Wei X, Kou Y, You H
J Exp Clin Cancer Res. 2016; 35(1):172.
PMID: 27821177
PMC: 5100324.
DOI: 10.1186/s13046-016-0448-2.
Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.
Shi Y, Wang S, Yao M, Sai W, Wu W, Yang J
World J Gastroenterol. 2015; 21(45):12814-21.
PMID: 26668505
PMC: 4671036.
DOI: 10.3748/wjg.v21.i45.12814.
Genetic deletion of AEG-1 prevents hepatocarcinogenesis.
Robertson C, Srivastava J, Siddiq A, Gredler R, Emdad L, Rajasekaran D
Cancer Res. 2014; 74(21):6184-93.
PMID: 25193383
PMC: 4216744.
DOI: 10.1158/0008-5472.CAN-14-1357.